Drugs / Measles-Rubella vaccine Bio Farma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04183114 | Sep → Nov 2019 | congenital rubella syndrome, measles | PT Bio Farma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles-Rubella vaccine Bio Farma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04183114 ↗ |
| Modality | Vaccine | “Measles-Rubella vaccine Bio Farma” NCT04183114 ↗ |